Home LiteratureArticle Details
PMID: 21814561 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors.

PloS one ·Vol. 6 ·No. 7 ·2011-00-00 ·Pages e21896

Cui Y, Liu B, Luo S, Zhen X, Fan M, Liu T, Zhu W, Park M, Jiang T, Jin JS, Alzheimer's Disease Neuroimaging Initiative

Abstract

Prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is of major interest in AD research. A large number of potential predictors have been proposed, with most investigations tending to examine one or a set of related predictors. In this study, we simultaneously examined multiple features from different modalities of data, including structural magnetic resonance imaging (MRI) morphometry, cerebrospinal fluid (CSF) biomarkers and neuropsychological and functional measures (NMs), to explore an optimal set of predictors of conversion from MCI to AD in an Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. After FreeSurfer-derived MRI feature extraction, CSF and NM feature collection, feature selection was employed to choose optimal subsets of features from each modality. Support vector machine (SVM) classifiers were then trained on normal control (NC) and AD participants. Testing was conducted on MCIc (MCI individuals who have converted to AD within 24 months) and MCInc (MCI individuals who have not converted to AD within 24 months) groups. Classification results demonstrated that NMs outperformed CSF and MRI features. The combination of selected NM, MRI and CSF features attained an accuracy of 67.13%, a sensitivity of 96.43%, a specificity of 48.28%, and an AUC (area under curve) of 0.796. Analysis of the predictive values of MCIc who converted at different follow-up evaluations showed that the predictive values were significantly different between individuals who converted within 12 months and after 12 months. This study establishes meaningful multivariate predictors composed of selected NM, MRI and CSF measures which may be useful and practical for clinical diagnosis.

MeSH Terms
Aged Alzheimer Disease/cerebrospinal fluid,diagnosis,etiology Biomarkers/cerebrospinal fluid Cognitive Dysfunction/cerebrospinal fluid,complications,diagnosis Disease Progression Female Humans Image Processing, Computer-Assisted Magnetic Resonance Imaging Male Neuroimaging Neuropsychological Tests Predictive Value of Tests Support Vector Machine
Chemicals
Biomarkers
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Cui Yue
School of Design, Communication and Information Technology, University of Newcastle, Newcastle, New South Wales, Australia.
Liu Bing
Luo Suhuai
Zhen Xiantong
Fan Ming
Liu Tao
Zhu Wanlin
Park Mira
Jiang Tianzi
Jin Jesse S
Alzheimer's Disease Neuroimaging Initiative
References (45)
45 references, click to expand
  1. Predicting conversion from mild cognitive impairment to Alzheimer's disease using neuropsychological tests and multivariate methods.
    J Clin Exp Neuropsychol. 2011 Feb;33(2):187-99 PMID: 20711906
  2. The clinical use of structural MRI in Alzheimer disease.
    Nat Rev Neurol. 2010 Feb;6(2):67-77 PMID: 20139996
  3. Multi-modal imaging predicts memory performance in normal aging and cognitive decline.
    Neurobiol Aging. 2010 Jul;31(7):1107-21 PMID: 18838195
  4. Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative.
    Alzheimers Dement. 2010 May;6(3):212-20 PMID: 20451869
  5. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI.
    Neuroimage. 2009 Feb 15;44(4):1415-22 PMID: 19027862
  6. Automatically parcellating the human cerebral cortex.
    Cereb Cortex. 2004 Jan;14(1):11-22 PMID: 14654453
  7. Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study.
    Neuroimage. 2008 Jun;41(2):277-85 PMID: 18400519
  8. Brain ERP components predict which individuals progress to Alzheimer's disease and which do not.
    Neurobiol Aging. 2011 Oct;32(10):1742-55 PMID: 20005599
  9. Temporoparietal MR imaging measures of atrophy in subjects with mild cognitive impairment that predict subsequent diagnosis of Alzheimer disease.
    AJNR Am J Neuroradiol. 2009 Mar;30(3):532-8 PMID: 19112067
  10. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.
    Neuron. 2002 Jan 31;33(3):341-55 PMID: 11832223
  11. Sequence-independent segmentation of magnetic resonance images.
    Neuroimage. 2004;23 Suppl 1:S69-84 PMID: 15501102
  12. Advances in the early detection of Alzheimer's disease.
    Nat Med. 2004 Jul;10 Suppl:S34-41 PMID: 15298007
  13. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis.
    Neuropsychology. 2005 Jul;19(4):520-31 PMID: 16060827
  14. Current concepts in Alzheimer's disease: a multidisciplinary review.
    Am J Alzheimers Dis Other Demen. 2009 Apr-May;24(2):95-121 PMID: 19116299
  15. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.
    Lancet Neurol. 2006 Mar;5(3):228-34 PMID: 16488378
  16. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.
    J Psychiatr Res. 1975 Nov;12(3):189-98 PMID: 1202204
  17. Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease.
    Neuroimage. 2009 Apr 15;45(3):656-61 PMID: 19280688
  18. Measurement of functional activities in older adults in the community.
    J Gerontol. 1982 May;37(3):323-9 PMID: 7069156
  19. Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging.
    Neurobiol Aging. 2008 Apr;29(4):514-23 PMID: 17174012
  20. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
    Neurology. 2007 Mar 13;68(11):828-36 PMID: 17353470
  21. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.
    Ann Neurol. 2009 Apr;65(4):403-13 PMID: 19296504
  22. Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database.
    Neuroimage. 2011 May 15;56(2):766-81 PMID: 20542124
  23. Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline.
    Neuroimage. 2008 Feb 15;39(4):1731-43 PMID: 18053747
  24. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.
    Neurology. 2010 Jan 19;74(3):201-9 PMID: 20042704
  25. The Clock Test: a sensitive measure to differentiate normal elderly from those with Alzheimer disease.
    J Am Geriatr Soc. 1992 Jun;40(6):579-84 PMID: 1587974
  26. Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve.
    Brain. 2009 Aug;132(Pt 8):2036-47 PMID: 19439419
  27. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
    JAMA. 2009 Jul 22;302(4):385-93 PMID: 19622817
  28. Biomarkers for early detection of Alzheimer pathology.
    Neurosignals. 2008;16(1):11-8 PMID: 18097155
  29. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.
    J Magn Reson Imaging. 2008 Apr;27(4):685-91 PMID: 18302232
  30. Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.
    AJNR Am J Neuroradiol. 2010 Feb;31(2):347-54 PMID: 20075088
  31. Multimodal classification of Alzheimer's disease and mild cognitive impairment.
    Neuroimage. 2011 Apr 1;55(3):856-67 PMID: 21236349
  32. Automated MRI measures predict progression to Alzheimer's disease.
    Neurobiol Aging. 2010 Aug;31(8):1364-74 PMID: 20570399
  33. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest.
    Neuroimage. 2006 Jul 1;31(3):968-80 PMID: 16530430
  34. Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment.
    Radiology. 2009 Apr;251(1):195-205 PMID: 19201945
  35. Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance.
    Neurobiol Aging. 2012 Jul;33(7):1203-14 PMID: 21159408
  36. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD.
    Neurobiol Aging. 2004 Oct;25(9):1197-203 PMID: 15312965
  37. Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies.
    Neuroimage. 2008 Feb 1;39(3):1186-97 PMID: 18054253
  38. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.
    Neurology. 1984 Jul;34(7):939-44 PMID: 6610841
  39. Amnestic mild cognitive impairment: difference of memory profile in subjects who converted or did not convert to Alzheimer's disease.
    Neuropsychology. 2007 Sep;21(5):549-58 PMID: 17784803
  40. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.
    Curr Alzheimer Res. 2009 Aug;6(4):347-61 PMID: 19689234
  41. Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment.
    Neuroimage. 2011 May 1;56(1):212-9 PMID: 21272654
  42. Minimum redundancy feature selection from microarray gene expression data.
    J Bioinform Comput Biol. 2005 Apr;3(2):185-205 PMID: 15852500
  43. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification.
    Neurobiol Aging. 2011 Dec;32(12):2322.e19-27 PMID: 20594615
  44. The Clinical Dementia Rating (CDR): current version and scoring rules.
    Neurology. 1993 Nov;43(11):2412-4 PMID: 8232972
  45. Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy.
    IEEE Trans Pattern Anal Mach Intell. 2005 Aug;27(8):1226-38 PMID: 16119262
Article Info
Journal
PloS one
Abbr.
PLoS One
ISSN
1932-6203
Published
2011-00-00
Epub
2011-00-21
Pages
e21896
Language
English
Region
United States
NLM ID
101285081
PMCID
PMC3140993
Subset
IM
Grants
NIA NIH HHS · K01 AG030514 · United States
NIA NIH HHS · P30 AG010129 · United States
NIA NIH HHS · U01 AG024904 · United States
NIA NIH HHS · U19 AG010483 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]